>アジア太平洋地域の健康スクリーニング市場、検査タイプ別(コレステロール検査、糖尿病検査、がんスクリーニング、一般健康診断、性感染症、血圧検査など)、パッケージタイプ別(基本健康スクリーニング、高齢者プロファイル、女性健康診断、男性健康診断、心臓検査、糖尿病検査など)、パネルタイプ別(マルチテストパネルおよびシングルテストパネル)、サンプルタイプ別(血液、尿、血清、唾液など)、技術別(免疫アッセイ、医療用画像、QPCR(定量的ポリメラーゼ連鎖反応)、Q-FISH(定量的蛍光、in situハイブリダイゼーション)、TRF(末端制限断片)、STELA(単一テロメア長分析)など)、病状別(心血管疾患、代謝障害、がん、炎症性疾患、筋骨格障害、神経疾患、C型肝炎合併症、免疫関連疾患など)サンプル収集場所(病院、自宅、診断研究所、オフィスなど)、流通チャネル(直接入札、小売販売など)、国(日本、中国、韓国、インド、オーストラリア、シンガポール、タイ、マレーシア、インドネシア、フィリピン、ベトナム、その他のアジア太平洋地域)業界の動向と2028年までの予測。
市場分析と洞察: アジア太平洋地域の健康診断市場
アジア太平洋地域の健康診断市場は、2021年から2028年の予測期間に市場が成長すると予想されています。データブリッジマーケットリサーチは、市場は2021年から2028年の予測期間に13.6%のCAGRで成長し、2028年までに109,704.00百万米ドルに達すると分析しています。慢性疾患の増加、高齢者人口、病気の早期発見と治療に関する意識の高まりは、予測期間における市場の需要を推進する主な原動力です。
健康診断は、特定の疾患を早期に発見するための重要な方法です。スクリーニング検査は、個人が疾患の危険因子の初期兆候を示しているかどうかを特定するために、予防医学でよく使用されます。スクリーニングによって検出される可能性のある疾患には、がん、糖尿病、高コレステロール、高血圧、骨粗しょう症などがあります。
病気の早期発見と治療に対する人々の意識の高まりと医療費の増加により、健康診断の需要が高まっています。
健康診断の有効性による需要の高まり、サービス提供者数の増加、健康診断の民間および公的機関による啓発キャンペーンの強化により、予測期間中の健康診断市場の成長が促進されます。ただし、スクリーニング検査のコストが高いため、予測期間中の市場の成長が妨げられる可能性があります。
アジア太平洋地域の健康スクリーニング市場レポートでは、市場シェア、新開発、製品パイプライン分析、国内および現地の市場プレーヤーの影響の詳細を提供し、新たな収益源、市場規制の変更、製品承認、戦略的決定、製品発売、地理的拡大、市場における技術革新の観点からの機会を分析します。分析と市場シナリオを理解するには、アナリスト概要についてお問い合わせください。当社のチームが、収益に影響を与えるソリューションを作成し、希望する目標を達成できるようお手伝いします。
アジア太平洋地域の健康診断市場の範囲と市場規模
アジア太平洋地域の健康診断市場は、検査タイプ、パッケージタイプ、パネルタイプ、サンプルタイプ、技術、状態、サンプル収集場所、流通チャネルに基づいて、8 つの主要なセグメントに分割されています。セグメント間の成長は、ニッチな成長分野と市場にアプローチするための戦略を分析し、コア アプリケーション領域とターゲット市場の違いを決定するのに役立ちます。
- 検査の種類に基づいて、アジア太平洋地域の健康診断市場は、コレステロール検査、糖尿病検査、がんスクリーニング、一般健康診断、性感染症、血圧検査などに分類されます。2021年には、高齢者人口の増加と座りがちなライフスタイルにより、コレステロール検査セグメントが市場を支配すると予想されます。
- パッケージタイプに基づいて、アジア太平洋地域の健康診断市場は、基本的な健康診断、高齢者プロファイル、女性の健康診断、男性の健康診断、心臓検査、糖尿病検査などに分類されます。2021年には、アジア諸国での医療費の増加により、基本的な健康診断セグメントが市場を支配すると予想されます。
- パネルの種類に基づいて、アジア太平洋地域の健康スクリーニング市場は、マルチテストパネルとシングルテストパネルに分割されています。2021年には、この地域の検査室の技術的進歩により、マルチテストパネルセグメントが市場を支配すると予想されています。
- サンプルの種類に基づいて、アジア太平洋地域の健康診断市場は、血液、尿、血清、唾液、その他に分類されます。2021年には、血液セグメントが市場を支配すると予想されます。これは、サンプルの種類が最も多く、ほぼすべての研究室で診断できるためです。
- 技術に基づいて、アジア太平洋地域の健康スクリーニング市場は、免疫測定、医療用画像、QPCR(定量的ポリメラーゼ連鎖反応)、Q-FISH(定量的蛍光、in situハイブリダイゼーション)、TRF(末端制限断片)、STELA(単一テロメア長分析)などに分割されています。2021年には、アジア市場は医療ツーリズムの成長を伴う新興ヘルスケア市場の1つであり、この理由からすべてのスクリーニング技術の需要が増加すると予想されるため、免疫測定セグメントが市場を支配すると予想されます。
- アジア太平洋地域の健康スクリーニング市場は、病状に基づいて、心血管疾患、代謝障害、癌、炎症性疾患、筋骨格障害、神経疾患、C型肝炎合併症、免疫関連疾患などに区分されています。2021年には、この地域でも心血管疾患の有病率が高いため、心血管疾患セグメントが市場を支配すると予想されています。
- サンプル収集場所に基づいて、アジア太平洋地域の健康スクリーニング市場は、病院、家庭、診断研究所、オフィス、その他に分類されます。2021年には、アジア太平洋地域で病院数の増加に伴いインフラが成長しているため、病院セグメントが市場を支配すると予想されます。
- 流通チャネルに基づいて、アジア太平洋地域の健康診断市場は、直接入札、小売販売、その他に分類されます。2021年には、健康診断プログラムの全体的な売上の増加により、直接入札セグメントが市場を支配すると予想されます。
アジア太平洋地域の健康診断市場の国別分析
アジア太平洋地域の健康診断市場を分析し、検査タイプ、パッケージタイプ、パネルタイプ、サンプルタイプ、技術、条件、サンプル収集場所、流通チャネルに関する市場規模情報を提供します。
アジア太平洋地域の健康スクリーニング市場レポートで取り上げられている国は、日本、中国、韓国、インド、オーストラリア、シンガポール、タイ、マレーシア、インドネシア、フィリピン、ベトナム、その他のアジア太平洋諸国です。アジア太平洋地域のインドは、革新的な研究開発と新製品の発売および承認により、2021年から2028年の予測期間に最も高い成長率で成長すると予想されています。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える個別の市場影響要因と市場規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、個々の国の市場シナリオを予測するために使用される主要な指標の一部です。また、アジア太平洋ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面する課題、販売チャネルの影響を考慮しながら、国別データの予測分析を提供します。
高齢者人口の増加とがんおよびCVD疾患の発症率の上昇により、アジア太平洋地域の健康スクリーニング製品の市場成長が促進されています。
アジア太平洋地域の健康診断市場では、医薬品の販売、進歩の影響、技術、規制シナリオの変化と健康診断市場へのサポートに関する各国の健康診断製品産業の成長に関する詳細な市場分析も提供しています。データは、2010年から2019年までの履歴期間について入手できます。
競争環境とアジア太平洋地域の 健康診断市場シェア分析
アジア太平洋地域の健康スクリーニング市場の競争状況は、競合他社の詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と幅、アプリケーションの優位性、技術ライフライン曲線などがあります。提供されている上記のデータ ポイントは、アジア太平洋地域の健康スクリーニング市場に関連する会社の焦点にのみ関連しています。
アジア太平洋地域の健康スクリーニング市場に参入している主要企業としては、Sonic Healthcare Limited、Quest Diagnostics Incorporated、Healius Limited、Quidel Corporation、Eurofins Scientific、GRAIL、、Exact Sciences Corporation、SYNLAB International GmbH、UNILABS、LabPLUS、BioReference Laboratories、、ACM Global Laboratories、Cerba Healthcare、、Innova Medical Group、AMEDES Holding GmbH、RadNet, Inc.、Natera, Inc.、Trinity Biotech、Nuffield Health、RepeatDx、NeoGenomics Laboratories、HU Group Holdings, Inc.、Lifelabs、ARUP Laboratories、Q2 Solutions、Genova Diagnostics、Life Length、DNA Labs India、、Telomere Diagnostics、Charles River Laboratories、Ambry Genetics、SpectraCell Laboratories, Inc.、Dr. Lal PathLabs、Laboratory Corporation of Americaなどがあります。
世界中の企業によって多くの製品の発売や契約も開始されており、これもアジア太平洋地域の健康診断市場を加速させています。
例えば、
- 2020年3月、ソニックヘルスケアは病理学診療研究所であるPathologie Hamburgを買収したことを発表しました。この買収により、同社は生産能力と検査能力が向上しました。2020年9月、Healius LimitedはVirtus Healthと販売契約を結び、adora Fertilityを買収したことを発表しました。これにより、予測期間中に同社の市場が拡大するでしょう。
市場プレーヤーによるコラボレーション、製品の発売、事業拡大、賞や表彰、合弁事業、その他の戦略により、健康診断市場における企業市場が強化され、組織が健康診断の提供を改善するメリットももたらされます。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC HEALTH SCREENING MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TEST TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 DISTRIBUTION CHANNELUSER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 REGULATIONS
5.1 WORLD HEALTH ORGANIZATION
5.2 NORTH AMERICA
5.3 EUROPE
6 INDUSTRIAL INSIGHTS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISING PREVALENCE OF CHRONIC DISEASES
7.1.2 GROWING GERIATRIC POPULATION
7.1.3 GOVERNMENT INITIATIVES UNDERTAKEN TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES
7.1.4 RISING PER CAPITA INCOME AND HEALTHCARE EXPENDITURE
7.1.5 GRWOING NUMBER OF SCREENING PROGRAMS WORLDWIDE
7.2 RESTRAINTS
7.2.1 SCRACITY OF TECHNICALLY-SKILLED PROFESSIONALS
7.2.2 RISKS ASSOCIATED WITH SCREENING
7.2.3 LACK OF ACCESSIBILITY
7.3 OPPORTUNITIES
7.3.1 TECHNOLOGICAL ADVANCEMENTS IN HEALTH SCREENING
7.3.2 ACQUSITIONS AND MERGERS AMONG THE MARKET
7.3.3 NEW PRODUCT LAUNCHES IN THE MARKET
7.4 CHALLENGES
7.4.1 HIGHER COST OF HEALTH SCREENING
7.4.2 OPERATIONAL BARRIERS FACED IN CONDUCTING SCREENING TESTS
8 COVID-19 IMPACT ON ASIA PACIFIC HEALTH SCREENING MARKET
8.1 PRICE IMPACT
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC DECISIONS FOR MANUFACTURERS
8.5 CONCLUSION
9 ASIA PACIFIC HEALTH SCREENING MARKET, BY TEST TYPE
9.1 OVERVIEW
9.2 CHOLESTEROL TESTS
9.2.1 TOTAL CHOLESTEROL TESTS
9.2.2 TRIGLYCERIDES
9.2.3 LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL
9.2.4 HIGH-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL
9.3 DIABETES TEST
9.3.1 FASTING/RANDOM BLOOD SUGAR TEST
9.3.2 A1C TEST
9.3.3 GLUCOSE TOLERANCE TEST
9.4 CANCER SCREENING
9.4.1 LIQUID BIOPSY
9.4.2 MAMMOGRAMS, OSTEOPOROSIS, BREAST MRI AND PAP SMEAR TESTS
9.4.3 LOW-DOSE HELICAL COMPUTED TOMOGRAPHY
9.4.4 COLORECTAL CANCER SCREENING TEST (STOOL TESTS, SIGMOIDOSCOPY, COLONOSCOPY, BLOOD-BASED DNA TEST, DOUBLE-CONTRAST BARIUM ENEMA (DCBE), AND SINGLE-SPECIMEN GFOBT)
9.4.5 PROSTATE SPECIFIC ANTIGEN (PSA) TEST
9.4.6 NEW-EARLY DETECTION CANCER TESTS
9.4.7 ALPHA FETOPROTEIN BLOOD TEST
9.4.8 CA-125 TEST
9.4.9 OTHERS
9.5 GENERAL CHECK UP TEST
9.5.1 REGULAR CHECK UP
9.5.1.1 REGULAR BLOOD TEST
9.5.1.2 X-RAYS
9.5.1.3 ECG
9.5.1.4 FECALYSIS
9.5.1.5 URINALYSIS
9.5.1.6 BMI
9.5.1.7 OTHERS
9.5.2 EYE CHECK UP
9.5.3 DENTAL TEST
9.5.4 HEARING TEST
9.6 STD’S
9.6.1 CHLAMYDIA
9.6.2 GONORRHEA
9.6.3 HPV
9.6.4 HIV
9.6.5 OTHERS
9.7 BLOOD PRESSURE TEST
9.8 OTHERS
9.8.1 LIVER FUNCTION TESTS
9.8.2 KIDNEY PROFILE
9.8.3 OTHERS
10 ASIA PACIFIC HEALTH SCREENING MARKET, BY PANEL TYPE
10.1 OVERVIEW
10.2 MULTI-TEST PANELS
10.3 SINGLE-TEST PANELS
10.3.1 INFLAMMATION TESTS
10.3.2 OXIDATIVE STRESS TESTS
10.3.3 HEAVY METAL TESTS
10.3.4 TELOMERE
11 ASIA PACIFIC HEALTH SCREENING MARKET, BY PACKAGE TYPE
11.1 OVERVIEW
11.2 BASIC HEALTH SCREENING
11.3 SENIOR CITIZEN PROFILE
11.4 WOMEN HEALTH CHECK
11.5 MEN HEALTH CHECK
11.6 HEART CHECK
11.7 DIABETES CHECK
11.8 OTHERS
12 ASIA PACIFIC HEALTH SCREENING MARKET, BY SAMPLE TYPE
12.1 OVERVIEW
12.2 BLOOD
12.3 URINE
12.4 SERUM
12.5 SALIVA
12.6 OTHERS
13 HEALTH SCREENING MARKET, BY TECHNOLOGY
13.1 OVERVIEW
13.2 IMMUNOASSAYS
13.3 MEDICAL IMAGING
13.4 QPCR
13.4.1 MMQPCR (MONOCHROME MULTIPLEX QPCR)
13.4.2 ATLQPCR (ABSOLUTE TELOMERE LENGTH QPCR)
13.5 Q-FISH
13.5.1 PRINS (PRIMED IN SITU SUBTYPE OF Q-FISH)
13.5.2 FLOW-FISH
13.5.3 HT Q-FISH (HIGH THROUGHPUT Q-FISH)
13.6 TRF (TERMINAL RESTRICTION FRAGMENT)
13.7 STELA (SINGLE TELOMERE LENGTH ANALYSIS)
13.8 OTHERS
14 ASIA PACIFIC HEALTH SCREENING MARKET, BY CONDITION
14.1 OVERVIEW
14.2 CARDIOVASCULAR DISEASE
14.2.1 CORONARY HEART DISEASE
14.2.2 ATHEROSCLEROSIS
14.3 METABOLIC DISORDERS
14.3.1 DIABETES MELLITUS
14.3.2 OBESITY
14.4 CANCER
14.5 INFLAMMATORY CONDITIONS
14.5.1 AUTOIMMUNE CONDITIONS
14.5.2 ALLERGIES
14.5.3 ARTHRITIS
14.5.4 ASTHMA
14.5.5 INFLAMMATORY DIGESTIVE PROBLEMS
14.6 MUSCULOSKELETAL DISORDERS
14.6.1 OSTEOPOROSIS
14.6.2 RHEUMATOID ARTHRITIS
14.7 NEUROLOGICAL CONDITIONS
14.7.1 CHRONIC STRESS
14.7.2 ALZHEIMER'S DISEASE
14.8 IMMUNOLOGY-RELATED CONDITIONS
14.9 HEPATITIS C COMPLICATIONS
14.1 OTHERS
15 HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 DIRECT TENDERS
15.3 RETAIL SALES
15.4 OTHERS
16 ASIA PACIFIC HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES
16.1 OVERVIEW
16.2 HOSPITAL
16.2.1 ACUTE CARE HOSPITALS
16.2.2 LONG-TERM CARE HOSPITALS
16.2.3 NURSING FACILITIES
16.2.4 REHABILITATION CENTERS
16.3 HOME
16.4 DIAGNOSTIC LABORATORIES
16.5 OFFICES
16.6 OTHERS
17 ASIA PACIFIC HEALTH SCREENING MARKET, BY REGION
17.1 ASIA-PACIFIC
17.1.1 JAPAN
17.1.2 INDIA
17.1.3 SOUTH KOREA .
17.1.4 AUSTRALIA
17.1.5 SINGAPORE
17.1.6 THAILAND
17.1.7 MALAYSIA
17.1.8 INDONESIA
17.1.9 PHILIPPINES
17.1.10 REST OF ASIA-PACIFIC
18 ASIA PACIFIC HEALTH SCREENING MARKET: COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
19 SWOT ANALYSIS
20 COMPANY PROFILE
20.1 QUEST DIAGNOSTICS INCORPORATED
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 COMPANY SHARE ANALYSIS
20.1.4 PRODUCT PORTFOLIO
20.1.5 RECENT DEVELOPMENTS
20.2 SONIC HEALTHCARE LIMITED
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 COMPANY SHARE ANALYSIS
20.2.4 PRODUCT PORTFOLIO
20.2.5 RECENT DEVELOPMENTS
20.3 LABORATORY CORPORATION OF AMERICA
20.3.1 COMPANY SNAPSHOT
20.3.2 REVENUE ANALYSIS
20.3.3 COMPANY SHARE ANALYSIS
20.3.4 PRODUCT PORTFOLIO
20.3.5 RECENT DEVELOPMENT
20.4 EUROFINS SCIENTIFIC
20.4.1 COMPANY SNAPSHOT
20.4.2 REVENUE ANALYSIS
20.4.3 COMPANY SHARE ANALYSIS
20.4.4 PRODUCT PORTFOLIO
20.4.5 RECENT DEVELOPMENTS
20.5 EXACT SCIENCES CORPORATION
20.5.1 COMPANY SNAPSHOT
20.5.2 REVENUE ANALYSIS
20.5.3 COMPANY SHARE ANALYSIS
20.5.4 PRODUCT PORTFOLIO
20.5.5 RECENT DEVELOPMENTS
20.6 ACM ASIA PACIFIC LABORATORIES
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENT
20.7 AMEDES
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENT
20.8 AMBRY GENETICS
20.8.1 COMPANY SNAPSHOT
20.8.2 SERVICE PORTFOLIO
20.8.3 RECENT DEVELOPMENTS
20.9 ARUP LABORATORIES
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENTS
20.1 BIOREFRENCE LABORATORIES
20.10.1 COMPANY SNAPSHOT
20.10.2 REVENUE ANALYSIS
20.10.3 PRODUCT PORTFOLIO
20.10.4 RECENT DEVELOPMENTS
20.11 CHARLES RIVER
20.11.1 COMPANY SNAPSHOT
20.11.2 REVENUE ANALYSIS
20.11.3 PRODUCT PORTFOLIO
20.11.4 RECENT DEVELOPMENTS
20.12 CERBA HEALTHCARE
20.12.1 COMPANY SNAPSHOT
20.12.2 PRODUCT PORTFOLIO
20.12.3 RECENT DEVELOPMENT
20.13 DNA LABS INDIA
20.13.1 COMPANY SNAPSHOT
20.13.2 SERVICE PORTFOLIO
20.13.3 RECENT DEVELOPMENT
20.14 DR LAL PATH LABS
20.14.1 COMPANY SNAPSHOT
20.14.2 REVENUE ANALYSIS
20.14.3 PRODUCT PORTFOLIO
20.14.4 RECENT DEVELOPMENT
20.15 GENOVA DIGNOSTICS
20.15.1 COMPANY SNAPSHOT
20.15.2 SERVICE PORTFOLIO
20.15.3 RECENT DEVELOPMENT
20.16 GRAIL
20.16.1 COMPANY SNAPSHOT
20.16.2 SERVICE PORTFOLIO
20.16.3 RECENT DEVELOPMENTS
20.17 HEALIUS LIMITED
20.17.1 COMPANY SNAPSHOT
20.17.2 REVENUE ANALYSIS
20.17.3 PRODUCT PORTFOLIO
20.17.4 RECENT DEVELOPMENTS
20.18 H.U. GROUP HOLDINGS, INC.
20.18.1 COMPANY SNAPSHOT
20.18.2 REVENUE ANALYSIS
20.18.3 PRODUCT PORTFOLIO
20.18.4 RECENT DEVELOPMENTS
20.19 INNOVA MEDICAL GROUP
20.19.1 COMPANY SNAPSHOT
20.19.2 PRODUCT PORTFOLIO
20.19.3 RECENT DEVELOPMENT
20.2 LABPLUS
20.20.1 COMPANY SNAPSHOT
20.20.2 PRODUCT PORTFOLIO
20.20.3 RECENT DEVELOPMENT
20.21 LIFELABS
20.21.1 COMPANY SNAPSHOT
20.21.2 SERVICE PORTFOLIO
20.21.3 RECENT DEVELOPMENTS
20.22 LIFE LENGTH
20.22.1 COMPANY SNAPSHOT
20.22.2 SERVICE PORTFOLIO
20.22.3 RECENT DEVELOPMENT
20.23 NATERA, INC.
20.23.1 COMPANY SNAPSHOT
20.23.2 REVENUE ANALYSIS
20.23.3 PRODUCT PORTFOLIO
20.23.4 RECENT DEVELOPMENTS
20.24 NEOGENOMICS LABORATORIES
20.24.1 COMPANY SNAPSHOT
20.24.2 REVENUE ANALYSIS
20.24.3 PRODUCT PORTFOLIO
20.24.4 RECENT DEVELOPMENTS
20.25 NUFFIELD HEALTH
20.25.1 COMPANY SNAPSHOT
20.25.2 PRODUCT PORTFOLIO
20.25.3 RECENT DEVELOPMENT
20.26 Q2 SOLUTIONS
20.26.1 COMPANY SNAPSHOT
20.26.2 SERVICE PORTFOLIO
20.26.3 RECENT DEVELOPMENTS
20.27 QUIDEL CORPORATION
20.27.1 COMPANY SNAPSHOT
20.27.2 REVENUE ANALYSIS
20.27.3 PRODUCT PORTFOLIO
20.27.4 RECENT DEVELOPMENTS
20.28 REPEATDX
20.28.1 COMPANY SNAPSHOT
20.28.2 PRODUCT PORTFOLIO
20.28.3 RECENT DEVELOPMENT
20.29 SONIC HEALTHCARE LIMITED
20.29.1 COMPANY SNAPSHOT
20.29.2 REVENUE ANALYSIS
20.29.3 PRODUCT PORTFOLIO
20.29.4 RECENT DEVELOPMENTS
20.3 SPECTRACELL LABORATORIES, INC.
20.30.1 COMPANY SNAPSHOT
20.30.2 SERVICE PORTFOLIO
20.30.3 RECENT DEVELOPMENT
20.31 SYNLAB INTERNATIONAL GMBH
20.31.1 COMPANY SNAPSHOT
20.31.2 PRODUCT PORTFOLIO
20.31.3 RECENT DEVELOPMENT
20.32 TELOMERE DIAGNOSTICS
20.32.1 COMPANY SNAPSHOT
20.32.2 SERVICE PORTFOLIO
20.32.3 RECENT DEVELOPMENT
20.33 TRINITY BIOTECH
20.33.1 COMPANY SNAPSHOT
20.33.2 REVENUE ANALYSIS
20.33.3 PRODUCT PORTFOLIO
20.33.4 RECENT DEVELOPMENT
20.34 UNILABS
20.34.1 COMPANY SNAPSHOT
20.34.2 PRODUCT PORTFOLIO
20.34.3 RECENT DEVELOPMENT
21 QUESTIONNAIRE
22 RELATED REPORTS
表のリスト
TABLE 1 NUMBER OF PEOPLE WITH DIABETES AMONG 20–79 YEARS OLD (IN MILLION)
TABLE 2 NEW CANCER CASES FOR AGE 85+ IN U.S.
TABLE 3 ACCORDING TO THE UNITED NATIONS, IN 2019, THE TOTAL POPULATION OF AGED PEOPLE ABOVE 65 WAS 703 MILLION AND IS EXPECTED TO REACH 1.5 BILLION BY 2050.
TABLE 4 PER CAPITA AMOUNTS: THE UNITED STATES (1960–2017)
TABLE 5 ASIA PACIFIC HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 6 ASIA PACIFIC CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 ASIA PACIFIC CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 8 ASIA PACIFIC DIABETES TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 ASIA PACIFIC DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 10 ASIA PACIFIC CANCER SCREENING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 ASIA PACIFIC CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 12 ASIA PACIFIC GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 ASIA PACIFIC GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 14 ASIA PACIFIC REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 15 ASIA PACIFIC STD’S IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 ASIA PACIFIC STD’S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 17 ASIA PACIFIC BLOOD PRESSURE TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 20 ASIA PACIFIC HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 21 ASIA PACIFIC MULTI-TEST PANELS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA PACIFIC SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 ASIA PACIFIC SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 24 ASIA PACIFIC HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 25 ASIA PACIFIC BASIC HEALTH SCREENING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA PACIFIC SENIOR CITIZEN PROFILE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 ASIA PACIFIC WOMEN HEALTH CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 ASIA PACIFIC MEN HEALTH CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA PACIFIC HEART CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 ASIA PACIFIC DIABETES CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 ASIA PACIFIC HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
TABLE 33 ASIA PACIFIC BLOOD IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 ASIA PACIFIC URINE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 ASIA PACIFIC SERUM IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 ASIA PACIFIC SALIVA IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 ASIA PACIFIC HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 39 ASIA PACIFIC IMMUNOASSAYS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 40 ASIA PACIFIC MEDICAL IMAGING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 41 ASIA PACIFIC QPCR IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 ASIA PACIFIC QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 43 ASIA PACIFIC Q-FISH IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 ASIA PACIFIC Q-FISH IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 45 ASIA PACIFIC TRF (TERMINAL RESTRICTION FRAGMENT) IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 46 ASIA PACIFIC STELA (SINGLE TELOMERE LENGTH ANALYSIS) IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 47 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 48 ASIA PACIFIC HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 49 ASIA PACIFIC CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 50 ASIA PACIFIC CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 51 ASIA PACIFIC METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 52 ASIA PACIFIC METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 53 ASIA PACIFIC CANCER IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 54 ASIA PACIFIC INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 55 ASIA PACIFIC INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 56 ASIA PACIFIC MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 57 ASIA PACIFIC MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 58 ASIA PACIFIC NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 59 ASIA PACIFIC NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 60 ASIA PACIFIC IMMUNOLOGY-RELATED CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 61 ASIA PACIFIC HEPATITIS-C COMPLICATIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 62 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 63 ASIA PACIFIC HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 64 ASIA PACIFIC DIRECT TENDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 65 ASIA PACIFIC RETAIL SALES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 66 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 67 ASIA PACIFIC HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 68 ASIA PACIFIC HOSPITAL IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 69 ASIA PACIFIC HOSPITAL IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 70 ASIA PACIFIC HOME IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 71 ASIA PACIFIC DIAGNOSTIC LABORATORIES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 72 ASIA PACIFIC OFFICES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 73 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 74 ASIA-PACIFIC HEALTH SCREENING MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 75 ASIA-PACIFIC HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 76 ASIA-PACIFIC CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 77 ASIA-PACIFIC DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 78 ASIA-PACIFIC CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 79 ASIA-PACIFIC GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 80 ASIA-PACIFIC REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 81 ASIA-PACIFIC STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 82 ASIA-PACIFIC OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 83 ASIA-PACIFIC HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 84 ASIA-PACIFIC HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 85 ASIA-PACIFIC SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 86 ASIA-PACIFIC HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 87 ASIA-PACIFIC HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 88 ASIA-PACIFIC QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 89 ASIA-PACIFIC Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 90 ASIA-PACIFIC HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 91 ASIA-PACIFIC CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 92 ASIA-PACIFIC METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 93 ASIA-PACIFIC INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 94 ASIA-PACIFIC MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 95 ASIA-PACIFIC NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 96 ASIA-PACIFIC HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 97 ASIA-PACIFIC HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 98 ASIA-PACIFIC HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 99 CHINA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 100 CHINA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 101 CHINA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 102 CHINA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 103 CHINA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 104 CHINA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 105 CHINA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 106 CHINA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 107 CHINA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 108 CHINA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 109 CHINA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 110 CHINA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 111 CHINA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 112 CHINA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 113 CHINA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 114 CHINA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 115 CHINA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 116 CHINA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 117 CHINA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 118 CHINA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 119 CHINA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 120 CHINA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 121 CHINA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 122 CHINA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 123 JAPAN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 124 JAPAN CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 125 JAPAN DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 126 JAPAN CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 127 JAPAN GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 128 JAPAN REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 129 JAPAN STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 130 JAPAN OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 131 JAPAN HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 132 JAPAN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 133 JAPAN SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 134 JAPAN HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 135 JAPAN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 136 JAPAN QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 137 JAPAN Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 138 JAPAN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 139 JAPAN CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 140 JAPAN METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 141 JAPAN INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 142 JAPAN MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 143 JAPAN NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 144 JAPAN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 145 JAPAN HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 146 JAPAN HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 147 INDIA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 148 INDIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 149 INDIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 150 INDIA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 151 INDIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 152 INDIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 153 INDIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 154 INDIA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 155 INDIA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 156 INDIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 157 INDIA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 158 INDIA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 159 INDIA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 160 INDIA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 161 INDIA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 162 INDIA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 163 INDIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 164 INDIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 165 INDIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 166 INDIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 167 INDIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 168 INDIA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 169 INDIA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 170 INDIA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 171 SOUTH KOREA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 172 SOUTH KOREA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 173 SOUTH KOREA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 174 SOUTH KOREA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 175 SOUTH KOREA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 176 SOUTH KOREA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 177 SOUTH KOREA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 178 SOUTH KOREA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 179 SOUTH KOREA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 180 SOUTH KOREA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 181 SOUTH KOREA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 182 SOUTH KOREA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 183 SOUTH KOREA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 184 SOUTH KOREA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 185 SOUTH KOREA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 186 SOUTH KOREA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 187 SOUTH KOREA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 188 SOUTH KOREA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 189 SOUTH KOREA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 190 SOUTH KOREA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 191 SOUTH KOREA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 192 SOUTH KOREA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 193 SOUTH KOREA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 194 SOUTH KOREA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 195 AUSTRALIA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 196 AUSTRALIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 197 AUSTRALIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 198 AUSTRALIA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 199 AUSTRALIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 200 AUSTRALIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 201 AUSTRALIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 202 AUSTRALIA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 203 AUSTRALIA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 204 AUSTRALIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 205 AUSTRALIA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 206 AUSTRALIA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 207 AUSTRALIA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 208 AUSTRALIA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 209 AUSTRALIA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 210 AUSTRALIA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 211 AUSTRALIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 212 AUSTRALIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 213 AUSTRALIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 214 AUSTRALIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 215 AUSTRALIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 216 AUSTRALIA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 217 AUSTRALIA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 218 AUSTRALIA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 219 SINGAPORE HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 220 SINGAPORE CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 221 SINGAPORE DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 222 SINGAPORE CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 223 SINGAPORE GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 224 SINGAPORE REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 225 SINGAPORE STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 226 SINGAPORE OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 227 SINGAPORE HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 228 SINGAPORE HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 229 SINGAPORE SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 230 SINGAPORE HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 231 SINGAPORE HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 232 SINGAPORE QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 233 SINGAPORE Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 234 SINGAPORE HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 235 SINGAPORE CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 236 SINGAPORE METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 237 SINGAPORE INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 238 SINGAPORE MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 239 SINGAPORE NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 240 SINGAPORE HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 241 SINGAPORE HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 242 SINGAPORE HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 243 THAILAND HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 244 THAILAND CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 245 THAILAND DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 246 THAILAND CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 247 THAILAND GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 248 THAILAND REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 249 THAILAND STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 250 THAILAND OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 251 THAILAND HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 252 THAILAND HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 253 THAILAND SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 254 THAILAND HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 255 THAILAND HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 256 THAILAND QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 257 THAILAND Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 258 THAILAND HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 259 THAILAND CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 260 THAILAND METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 261 THAILAND INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 262 THAILAND MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 263 THAILAND NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 264 THAILAND HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 265 THAILAND HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 266 THAILAND HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 267 MALAYSIA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 268 MALAYSIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 269 MALAYSIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 270 MALAYSIA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 271 MALAYSIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 272 MALAYSIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 273 MALAYSIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 274 MALAYSIA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 275 MALAYSIA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 276 MALAYSIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 277 MALAYSIA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 278 MALAYSIA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 279 MALAYSIA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 280 MALAYSIA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 281 MALAYSIA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 282 MALAYSIA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 283 MALAYSIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 284 MALAYSIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 285 MALAYSIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 286 MALAYSIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 287 MALAYSIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 288 MALAYSIA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 289 MALAYSIA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 290 MALAYSIA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 291 INDONESIA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 292 INDONESIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 293 INDONESIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 294 INDONESIA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 295 INDONESIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 296 INDONESIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 297 INDONESIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 298 INDONESIA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 299 INDONESIA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 300 INDONESIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 301 INDONESIA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 302 INDONESIA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 303 INDONESIA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 304 INDONESIA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 305 INDONESIA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 306 INDONESIA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 307 INDONESIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 308 INDONESIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 309 INDONESIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 310 INDONESIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 311 INDONESIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 312 INDONESIA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 313 INDONESIA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 314 INDONESIA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 315 PHILIPPINES HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 316 PHILIPPINES CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 317 PHILIPPINES DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 318 PHILIPPINES CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 319 PHILIPPINES GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 320 PHILIPPINES REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 321 PHILIPPINES STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 322 PHILIPPINES OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 323 PHILIPPINES HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 324 PHILIPPINES HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 325 PHILIPPINES SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 326 PHILIPPINES HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 327 PHILIPPINES HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 328 PHILIPPINES QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 329 PHILIPPINES Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 330 PHILIPPINES HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 331 PHILIPPINES CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 332 PHILIPPINES METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 333 PHILIPPINES INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 334 PHILIPPINES MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 335 PHILIPPINES NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 336 PHILIPPINES HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 337 PHILIPPINES HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 338 PHILIPPINES HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 339 REST OF ASIA-PACIFIC HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
図表一覧
FIGURE 1 ASIA PACIFIC HEALTH SCREENING MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC HEALTH SCREENING MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC HEALTH SCREENING MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC HEALTH SCREENING MARKET : ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC HEALTH SCREENING MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC HEALTH SCREENING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC HEALTH SCREENING MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA PACIFIC HEALTH SCREENING MARKET: MARKET DISTRIBUTION CHANNEL COVERAGE GRID
FIGURE 9 ASIA PACIFIC HEALTH SCREENING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC HEALTH SCREENING MARKET: SEGMENTATION
FIGURE 11 HIGH PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE ASIA PACIFIC HEALTH SCREENING MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 CHOLESTROL TESTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC HEALTH SCREENING MARKET IN 2021 & 2028
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE ASIA PACIFIC HEALTH SCREENING MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA PACIFIC HEALTH SCREENING MARKET
FIGURE 15 PREVALENCE OF CHRONIC DISEASES
FIGURE 16 AGING POPULATION IN THE WORLD (IN MILLION)
FIGURE 17 NORTH AMERICA AGING POPULATION (IN MILLION)
FIGURE 18 EUROPE AGING POPULATION (IN MILLION)
FIGURE 19 ASIA-PACIFIC AGING POPULATION (IN MILLION)
FIGURE 20 ASIA PACIFIC HEALTH SCREENING MARKET: BY TEST TYPE, 2020
FIGURE 21 ASIA PACIFIC HEALTH SCREENING MARKET: BY TEST TYPE, 2021-2028 (USD MILLION)
FIGURE 22 ASIA PACIFIC HEALTH SCREENING MARKET: BY TEST TYPE, CAGR (2021-2028)
FIGURE 23 ASIA PACIFIC HEALTH SCREENING MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 24 ASIA PACIFIC HEALTH SCREENING MARKET: BY PANEL TYPE, 2020
FIGURE 25 ASIA PACIFIC HEALTH SCREENING MARKET: BY PANEL TYPE, 2021-2028 (USD MILLION)
FIGURE 26 ASIA PACIFIC HEALTH SCREENING MARKET: BY PANEL TYPE, CAGR (2021-2028)
FIGURE 27 ASIA PACIFIC HEALTH SCREENING MARKET: BY PANEL TYPE, LIFELINE CURVE
FIGURE 28 ASIA PACIFIC HEALTH SCREENING MARKET: BY PACKAGE TYPE, 2020
FIGURE 29 ASIA PACIFIC HEALTH SCREENING MARKET: BY PACKAGE TYPE, 2021-2028 (USD MILLION)
FIGURE 30 ASIA PACIFIC HEALTH SCREENING MARKET: BY PACKAGE TYPE, CAGR (2021-2028)
FIGURE 31 ASIA PACIFIC HEALTH SCREENING MARKET: BY PACKAGE TYPE, LIFELINE CURVE
FIGURE 32 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE TYPE, 2020
FIGURE 33 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE TYPE, 2021-2028 (USD MILLION)
FIGURE 34 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE TYPE, CAGR (2021-2028)
FIGURE 35 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE TYPE, LIFELINE CURVE
FIGURE 36 ASIA PACIFIC HEALTH SCREENING MARKET: BY TECHNOLOGY, 2020
FIGURE 37 ASIA PACIFIC HEALTH SCREENING MARKET: BY TECHNOLOGY, 2021-2028 (USD MILLION)
FIGURE 38 ASIA PACIFIC HEALTH SCREENING MARKET: BY TECHNOLOGY, CAGR (2021-2028)
FIGURE 39 ASIA PACIFIC HEALTH SCREENING MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 40 ASIA PACIFIC HEALTH SCREENING MARKET: BY CONDITION, 2020
FIGURE 41 ASIA PACIFIC HEALTH SCREENING MARKET: BY CONDITION, 2021-2028 (USD MILLION)
FIGURE 42 ASIA PACIFIC HEALTH SCREENING MARKET: BY CONDITION, CAGR (2021-2028)
FIGURE 43 ASIA PACIFIC HEALTH SCREENING MARKET: BY CONDITION, LIFELINE CURVE
FIGURE 44 ASIA PACIFIC HEALTH SCREENING MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 45 ASIA PACIFIC HEALTH SCREENING MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 46 ASIA PACIFIC HEALTH SCREENING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 47 ASIA PACIFIC HEALTH SCREENING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 48 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE COLLECTION SITES, 2020
FIGURE 49 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE COLLECTION SITES, 2021-2028 (USD MILLION)
FIGURE 50 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE COLLECTION SITES, CAGR (2021-2028)
FIGURE 51 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE COLLECTION SITES, LIFELINE CURVE
FIGURE 52 ASIA-PACIFIC HEALTH SCREENING MARKET: SNAPSHOT (2020)
FIGURE 53 ASIA-PACIFIC HEALTH SCREENING MARKET: BY COUNTRY (2020)
FIGURE 54 ASIA-PACIFIC HEALTH SCREENING MARKET: BY COUNTRY (2021 & 2028)
FIGURE 55 ASIA-PACIFIC HEALTH SCREENING MARKET: BY COUNTRY (2020 & 2028)
FIGURE 56 ASIA-PACIFIC HEALTH SCREENING MARKET: BY TEST TYPE (2021-2028)
FIGURE 57 ASIA PACIFIC HEALTH SCREENING MARKET: COMPANY SHARE 2020(%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。